TriMas (TRS)
Makes packaging, life-sciences components, and compressed-gas cylinders after the Aerospace divestiture.
Something off on this page? Send us feedback.
Sells dispensing, closure, flexible-packaging, and life-sciences components through Packaging, plus Norris Cylinder compressed-gas cylinders through Specialty Products. Packaging is the dominant platform, and the business is now a two-segment manufacturer after divesting Aerospace.
Builds dispensing, closure, flexible-packaging, and life-sciences components through TriMas Packaging, alongside compressed-gas cylinders through Norris Cylinder in Specialty Products. Packaging is the dominant platform, while Specialty Products is the smaller industrial cylinder business.
Operates from Bloomfield Hills with a multi-country manufacturing footprint serving consumer packaging, life sciences, and industrial end markets. Execution is framed around customer success, technical expertise, focused innovation, quality, service, continuous improvement, and operational discipline.
Portfolio shape changed materially after the sales of Arrow Engine and TriMas Aerospace. Aerospace is historical context, not a continuing operating segment.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Feb 26, 2026 | KeyBanc | Target | Target: $45 | Target: $38 |
| Aug 13, 2025 | Keybanc | Upgrade |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $1.24B · Total debt $437.8M · Total assets $2.25B · Shareholders' equity $1.44B
- Revenue
- $174.6M
- Operating income
- $10.9M
- Net income
- $13.4M
HistoryDividendAnnual yield
| Institutions | ≈ 83.22% | 29.86M shares | |
|---|---|---|---|
| 213 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 19.43% | 6.97M shares | |
| 15 holders · as of Aug 14, 2026 | |||
| Adds to | 102.65% | ||
35.87M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 102.65%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Shawn Sedaghat1,2,3Insiderdirector, 10 percent owner | 16.88% | 6.05M | filed Jul 16, 2026 |
BlackRock, Inc.Institution | 7.05% | 2.53M | as of Jun 30, 2026 |
Dimensional Fund Advisors LPInstitution | 6.30% | 2.26M | as of Jun 30, 2026 |
Fiduciary Management Inc /WI/Institution | 5.61% | 2.01M | filed Feb 20, 2025 |
Allspring Global Investments Holdings, LLCInstitution | 5.31% | 1.90M | as of Jun 30, 2026 |
- Shawn Sedaghat's transaction reports restate only vehicles that traded; the 2026 ownership statement (6.05M) plus the 615 net shares acquired since is used instead.
- Shawn Sedaghat reports a block also reported by another filer; it is counted once, under that filer.
- Shawn Sedaghat reports a block also reported by Allspring Global Investments Holdings, LLC; it is counted once, under Allspring Global Investments Holdings, LLC.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 12, 2026 | Daniel P. Tredwell | director | +64 | $39.63 |
| Jun 30, 2026 | Herbert K. Parker | director | −15,000 | $45.03 |
| May 13, 2026 | Daniel P. Tredwell | director | +62 | $40.58 |
| May 7, 2026 | Jodi F. Robin | officer: General Counsel and Secretary | −2,000 | $41.61 |
| May 5, 2026 | Jodi F. Robin | officer: General Counsel and Secretary | −3,000 | $41.10 |
- AptarGroup
Direct overlap in dispensing, closures, and pharma delivery systems
- Silgan
Large dispensing and specialty-closures rival across consumer goods
- Amcor
Scale rival in flexible, rigid, healthcare, and closure packaging
- Greif Class A
Industrial drum and container-closure overlap through Tri-Sure
- West Pharmaceutical Services
Life-sciences components and pharma containment overlap
- Worthington Enterprises
Pressure-cylinder overlap in gas storage and transport
- Luxfer
High-pressure gas-cylinder alternative across medical and industrial uses
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| TriMas | $38.47 | +1.61% | $1.36B | 1.6 | 19.6 | 1.8 | −36.5% |
| AptarGroup | $125.41 | +1.63% | $7.88B | 22.3 | 21.1 | 2.0 | +6.3% |
| Silgan | $37.50 | +1.11% | $3.92B | 14.6 | 9.6 | 0.6 | +6.8% |
| Amcor | $42.91 | +1.79% | $19.49B | — | 9.9 | — | +25.9% |
| Greif Class A | $84.31 | +1.19% | $3.85B | — | 16.4 | — | +2.7% |
| West Pharmaceutical Services | $372.07 | +2.84% | $25.46B | 46.3 | 40.2 | 7.7 | +13.9% |
| Worthington Enterprises | $59.09 | +1.62% | $2.85B | 18.2 | 15.7 | 2.1 | +16.9% |
| Luxfer | $17.27 | +0.17% | $461.3M | 59.6 | 13.2 | 1.3 | −8.0% |
| Median | 22.3 | 15.7 | 2.0 | +6.8% |